IRIS
GURNARI, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.285
AS - Asia 4.335
EU - Europa 2.545
Continente sconosciuto - Info sul continente non disponibili 736
SA - Sud America 664
AF - Africa 58
OC - Oceania 7
Totale 14.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.121
SG - Singapore 2.146
IT - Italia 1.094
HK - Hong Kong 547
BR - Brasile 530
RU - Federazione Russa 452
CN - Cina 435
BD - Bangladesh 322
VN - Vietnam 304
JP - Giappone 191
FI - Finlandia 173
GB - Regno Unito 155
DE - Germania 144
IE - Irlanda 119
FR - Francia 93
NL - Olanda 90
KR - Corea 84
CA - Canada 79
IN - India 75
ID - Indonesia 68
AT - Austria 57
MX - Messico 51
AR - Argentina 47
SE - Svezia 37
ES - Italia 26
PL - Polonia 25
EC - Ecuador 22
TR - Turchia 22
ZA - Sudafrica 19
IQ - Iraq 17
IR - Iran 16
PY - Paraguay 16
CO - Colombia 14
UA - Ucraina 14
MA - Marocco 13
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
JO - Giordania 10
PH - Filippine 10
JM - Giamaica 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
CZ - Repubblica Ceca 8
DZ - Algeria 7
MY - Malesia 7
AL - Albania 6
AU - Australia 6
BE - Belgio 6
IL - Israele 6
RO - Romania 6
BY - Bielorussia 5
EG - Egitto 5
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
SA - Arabia Saudita 5
UY - Uruguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
HR - Croazia 4
TH - Thailandia 4
BG - Bulgaria 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
CR - Costa Rica 2
EU - Europa 2
GT - Guatemala 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
Totale 13.888
Salva come PNG Salva come JPEG
Città #
Singapore 896
Wilmington 658
Houston 607
San Jose 605
Hong Kong 542
Council Bluffs 378
Ashburn 355
Rome 294
Creede 182
Tokyo 181
Los Angeles 180
New York 173
Santa Clara 163
Beijing 159
Helsinki 132
Woodbridge 127
The Dalles 122
Fairfield 121
Dublin 112
Dallas 104
Chandler 100
Ho Chi Minh City 99
Buffalo 91
Milan 88
Moscow 79
Hanoi 65
Center 63
Seattle 56
Chicago 52
Jakarta 51
London 43
São Paulo 43
Medford 42
Nuremberg 41
Cambridge 38
Naples 37
North Bergen 35
Lauterbourg 34
Munich 30
Ann Arbor 29
Atlanta 29
Lappeenranta 29
Mexico City 28
Redondo Beach 27
Phoenix 26
Brooklyn 25
Orem 24
Vienna 23
Montreal 22
Boardman 21
Frankfurt am Main 21
Lawrence 20
Stockholm 20
Rio de Janeiro 19
Warsaw 19
Turin 18
Amsterdam 17
Bari 17
Palermo 17
Dearborn 16
Denver 16
Hackensack 16
Toronto 16
Bologna 15
Haiphong 15
Miami 15
Salt Lake City 15
Brasília 14
Parma 14
Baghdad 13
Johannesburg 13
Las Vegas 13
Belo Horizonte 12
Chennai 12
Da Nang 12
Kilburn 11
Pune 11
San Diego 11
Seoul 11
Washington 11
Amman 10
Guangzhou 10
Menlo Park 10
Monte Vista 10
Poplar 10
Boston 9
Curitiba 9
Engelhard 9
Guayaquil 9
Jacksonville 9
Milwaukee 9
Monte Porzio Catone 9
Mülheim 9
Philadelphia 9
Queens 9
Shanghai 9
Tashkent 9
Campinas 8
Charlotte 8
Columbus 8
Totale 8.093
Salva come PNG Salva come JPEG
Nome #
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia 502
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 350
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 345
The emerging role of measurable residual disease detection in AML in morphologic remission 330
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes 318
Immunologia dei trapianti e trapianto di cellule staminali ematopoietiche 278
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia 250
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study 232
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY 228
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 222
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders 212
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 201
Applications and efficiency of flow cytometry for leukemia diagnostics 197
From bench to bedside and beyond: Therapeutic scenario in acute myeloid leukemia 178
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 156
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 156
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters 144
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 142
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways 141
Culprit or innocent bystander? The case of a new fast-moving hemoglobin J variant in a pregnant woman 137
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response 136
A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management 134
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia 132
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy 123
Germline DDX41 mutations define a unique subtype of myeloid neoplasms 115
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 114
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression 114
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia 112
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics 109
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia 107
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges 106
A fatal case of peritonitis due to colonic localization of acute myeloid leukemia 104
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia 103
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 101
Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value 101
Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant 100
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 100
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding 100
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 99
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience 99
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML 99
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M 98
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design 98
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia 98
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia 94
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare t-cell lymphoma: a clinical challenge 93
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children? 93
Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature 92
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project 92
Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease 92
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies 91
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence 89
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 88
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia 88
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia 88
Have we reached a molecular era in myelodysplastic syndromes? 88
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 86
Landscape of biallelic DNMT3A mutant myeloid neoplasms 86
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 86
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT 85
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations 85
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia 82
Aplastic anemia: quo vadis? 81
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder 80
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 80
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood 78
Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes 76
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia 76
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia 76
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia 75
Copper Deficiency 74
Molecular landscape of immune pressure and escape in aplastic anemia 74
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation 73
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy 73
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria 72
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia 72
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients 71
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 71
Development and Validation of a Prediction Model of Outcome after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma 70
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee 70
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments 70
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS 70
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? 70
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation 68
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander? 68
Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution 67
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept 66
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype 66
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond 66
T-cell large granular lymphocytic leukemia associated with inclusion body myositis 66
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies 64
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia 64
The Renovated Face of EHA Classical Master Class: A Survey-based Evaluation on Behalf of the EHA Campus Working Group 64
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms 64
Clonal hematopoiesis in large granular lymphocytic leukemia 64
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes 63
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 63
Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria 62
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments 62
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 61
Totale 11.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.135
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022205 0 17 15 5 1 35 9 13 12 14 18 66
2022/20231.161 28 23 13 52 22 62 768 40 33 16 44 60
2023/2024670 91 37 51 45 67 121 70 47 35 36 12 58
2024/20253.647 52 489 248 162 49 162 252 372 453 378 566 464
2025/20266.420 455 377 661 485 459 254 800 753 761 480 577 358
2026/2027696 416 280 0 0 0 0 0 0 0 0 0 0
Totale 14.630